Literature DB >> 16622620

Once more confirmed: adjuvant radiotherapy and improved local control provide a significant survival benefit for early breast cancer patients.

Marie-Luise Sautter-Bihl, Rolf Sauer.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16622620     DOI： 10.1007/s00066-006-6701-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

Review 1.  [Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?].

Authors:  Frank Lohr; Felix Heggemann; Theano Papavassiliu; Mostafa El-Haddad; Oliver Tomé; Dietmar Dinter; Barbara Dobler; Uta Kraus-Tiefenbacher; Martin Borggrefe; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

2.  The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer.

Authors:  Vincent Vinh-Hung; Pauline T Truong; Wolfgang Janni; Nam Phong Nguyen; Georges Vlastos; Gábor Cserni; Melanie E Royce; Wendy A Woodward; Donald Promish; Patricia Tai; Guy Soete; Sabine Balmer-Majno; Bruno Cutuli; Guy Storme; Christine Bouchardy
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

3.  Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer.

Authors:  Seok Hyun Son; Kyu Hye Choi; Shin-Wook Kim
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

4.  Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery.

Authors:  Hilde Van Parijs; Truus Reynders; Karina Heuninckx; Dirk Verellen; Guy Storme; Mark De Ridder
Journal:  Radiat Oncol       Date:  2014-01-27       Impact factor: 3.481

5.  Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacy.

Authors:  Stefan Janssen; Christoph Glanzmann; Stephanie Lang; Sarah Verlaan; Tino Streller; Doris Wisler; Claudia Linsenmeier; Gabriela Studer
Journal:  Radiat Oncol       Date:  2014-07-24       Impact factor: 3.481
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.